Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function
Rong Yin,Jiwei Chang,Yashu Li,Zhuying Gao,Qiang Qiu,Qifan Wang,Guoqiang Han,Jihua Chai,Mengdie Feng,Peipei Wang,Tiantian Zhang,Xueqin Xie,Jin Hu,Ying Cheng,Chengli Guo,Jing Wang,Kexin Gao,Manman Cui,Shaoguang Li,Yuhuan Zheng,Wei Jiang,Yiguo Hu,Haojian Zhang,Qing-yong Yang
DOI: https://doi.org/10.1016/j.stem.2021.09.014
IF: 23.9
2022-01-01
Cell Stem Cell
Abstract:N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) on mRNA plays critical roles in various cellular processes. However, the landscape and dynamics of m<sup>6</sup>A modification in hematopoietic system remain unknown. Here, we delineate a comprehensive m<sup>6</sup>A landscape across hematopoietic hierarchy and uncover that IGF2BP2 is required for preserving the function of hematopoietic stem cells (HSCs). Our data reveal a cell-type-specific m<sup>6</sup>A landscape in hematopoiesis. m<sup>6</sup>A modifications arise mostly in the early stage of hematopoiesis and prefer to play distinct roles for determining mRNA fates in HSCs and committed progenitors. Mechanistically, increased m<sup>6</sup>A-IGF2BP2 expression controls transcriptional state and maintenance of HSCs. IGF2BP2 deficiency induces quiescence loss and impairs HSC function. Moreover, IGF2BP2 loss increases mitochondrial activity of HSCs by accelerating Bmi1 mRNA decay, leading to de-repression of mitochondria-related genes. Collectively, our results present a fascinating portrait of m<sup>6</sup>A modification of hematopoietic hierarchy and reveal a key role of IGF2BP2 in maintaining HSC function by restraining mitochondrial activity.
cell biology,cell & tissue engineering